SCHEMBL21786233

SCHEMBL21786233

CCCC(CO)c1ccccc1N

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.37
AOC3 Q16853 2/20 0.35
NOS3 P29474 2/20 0.35
NOS1 P29475 2/20 0.35
NOS2 P35228 2/20 0.35
CYP1A2 P05177 2/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
TSHR P16473 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC10 Q969S8 1/20 0.33
HDAC11 Q96DB2 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
HDAC9 Q9UKV0 1/20 0.33
HDAC5 Q9UQL6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27345128 0.89 CYP1A2 (0.40) ALDH1A1NOS3NOS1NOS2CYP1A2
SCHEMBL28122680 0.88 ALDH1A1 (0.42) ALDH1A1AOC3NOS3NOS1NOS2
SCHEMBL27861224 0.85 ALDH1A1 (0.39) ALDH1A1NOS3NOS1NOS2CYP1A2
SCHEMBL10889645 0.85 ALDH1A1 (0.39) ALDH1A1AOC3NOS3NOS1NOS2
SCHEMBL3940100 0.84 CYP3A4 (0.41) ALDH1A1NOS3NOS1NOS2CYP1A2
SCHEMBL21786215 0.81 ALDH1A1 (0.37) ALDH1A1AOC3NOS3NOS1NOS2
SCHEMBL14747967 0.80 CYSLTR2 (0.42) ALDH1A1CYP1A2CYP2C9CYP2C19HSD17B10
SCHEMBL26696609 0.79 TSHR (0.52) ALDH1A1AOC3CYP1A2CYP2C9CYP2C19
SCHEMBL4325088 0.79 ESR1 (0.41) ALDH1A1AOC3CYP1A2CYP2C9CYP2C19
SCHEMBL25475053 0.79 CYSLTR2 (0.44) ALDH1A1CYP1A2CYP2C9CYP2C19HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230047296-A1 Nrf2 REGULATORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2023-02-16 US disclosed
US-20200071310-A1 N-ARYL PYRAZOLES AS NRF2 REGULATORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2020-03-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230047296-A1 Nrf2 REGULATORS NFE2L2, KEAP1, NQO1 ALDH1A1 621/4885AOC3 2399/4885NOS3 1580/4885
US-20200071310-A1 N-ARYL PYRAZOLES AS NRF2 REGULATORS NFE2L2, NQO1, KEAP1 ALDH1A1 339/4885AOC3 856/4885NOS3 328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.